Moderna wins EU deal to supply up to 24M doses of RSV vaccine
Seeking Alpha ·
Moderna ( MRNA ) on Thursday announced an agreement with the European Commission to provide several EU nations with up to 24M doses of its mRESVIA vaccine targeted at the respiratory syncytial virus. As part of the contract, the Cambridge, Massachusetts-based biotech will deliver
DYAX Investor Sentiment
Bullish (Long) 52% · Bearish (Short) 48%
569 participants
Related News
- When will traffic at the Strait of Hormuz return to normal?
- While Wall Street Worries, This Cheap Warren Buffett Consumer Stock Is a Screaming Buy
- Taco Bell removes fresh produce items amid U.S. Cyclospora outbreak
- AMD in focus as it announces collaboration with 5C on gigascale AI campuses
- Salesforce receives downgrade to Sector Weight as Agentforce fails to gain momentum: KeyBanc
- Broad Market Gains Offset Big Tech Weakness